Learning Objectives:

• Define the prevalence of opioid exposure during pregnancy
• Review the data for adverse perinatal outcomes associated with opioid exposure in utero
• Describe common patient presentations of opioid use disorder during pregnancy
• Discuss medication management of opioid use disorder

Learning Objectives:

• Upon completion of the activity, participants will be able to describe the causes of pain
• Upon completion of the activity, participants will know what makes people susceptible to chronic pain
• Upon completion of the activity, participants will understand the role that physical therapists play in helping people overcome acute and chronic pain issues

Learning Objectives:

• Identify mindfulness techniques to use with their patients/clients
• Comprehend the methodology and usage of auricular acupuncture
• Identify when to use or refer a patient/client for auricular acupuncture
• Understand how mindfulness techniques are effective in assisting patients to manage withdrawal symptoms, emotional dysregulation, and impulsivity

Learning Objectives:

• Comprehended the complex network of cases against multiple pharmaceutical companies.
• Communicate knowledge of the extent of the programs being offered by LADOJ and how they can be accessed.
• Discuss the activities currently being undertaken by the LADOJ on the lawsuits, education and outreach, prevention and other programs provided by the LADOJ regarding opioid addiction.
• Discuss the current landscape of opioid lawsuits in Louisiana and provisions being made for the funds post settlements. It should be addressed because law makers are deciding were this funding will be spent.

Learning Objectives:

• To define the purpose and spirit of Motivational Interviewing when treating individuals with Opioids and other substance use disorders.
• To identify the signs and symptoms of different stages of opioid use and commonly abused prescription medications.
• Participants will identify key factors in developing an MI therapeutic alliance that will enable healthcare professionals to help clients express their feelings problems, and impact on behavior.
• Participants will explain and cite examples of various MI techniques ( e.g. OARS and RULE techniques) and the importance of partnership of the client and therapist throughout the treatment process.

Learning Objectives:

• Describe specific non-opioid treatment options for various acute and chronic pain conditions
• Identify treatable pain conditions and address them early in order to avoid unnecessary delays in treatment and improve patient outcomes
• Limit use of opioid medication in clinical practice to help prevent long-term complications of opioid addiction, dependence, tolerance, and diversion.
• Help change the public perception/misconception that opioid medications are first-line treatments and/or the only treatments for acute and chronic pain

Learning Objectives:

• Discuss the issues which precipitated the creation of the PMP.
• Identify the primary users of the PMP.
• Summarize the trend of opioid prescription numbers in the state over time.
• Describe the state PMP mandatory use law.

Learning Objectives:

• Comprehend the opioid epidemic
• Apply the Louisiana State Board Opioid Rules to a medical practice
• Discuss the alternatives to long-term opioid use
• Discuss multimodal pain control.
• Discuss clinical orthopedic and related research journal information.

Learning Objectives:

• Define/describe SAMHSA, DATA/X-waiver, and give overview of OUD treatment in this context
• Identify resources for those wishing to obtain the waiver, both for initial certification and ongoing support.
• Review ongoing changes and updates to DATA-waiver requirements.
• Demonstrate use in clinical vignettes to show real-world application of waiver, including cases where it is not required.

Learning Objectives:

• Identify non-opioid drug treatment classes, dosing, side effects, contraindications, drug interactions, and indications for use in adult patients in the ambulatory /outpatient setting
• Choose an appropriate non-opioid drug treatment for common ambulatory/outpatient disease states that require analgesics based on guideline recommendations, patient demographics, contraindications, side effects, dosing, adherence, and costs
• Formulate a treatment plan for monitoring, assessing treatment response, duration of use, follow up, and switching to alternative treatment options
• Apply alternative drug treatment strategies for unique patient populations/clinical scenarios

Learning Objectives:

• Upon completion of this activity the participant will have be able to implement harm reduction strategies in their OUD patients
• Upon completion of this activity the participant will be able to communicate harm reduction and patient safety strategies to both their patients and families
• Reduce stigma when talking to patients concerning treatment of addictive disorders
• To discuss harm reduction when starting MAT and to discuss the concept of “meeting a patient they’re at” while minimizing potential harm